These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23 related articles for article (PubMed ID: 25114808)
1. Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. Hoivik EA; Kusonmano K; Halle MK; Berg A; Wik E; Werner HM; Petersen K; Oyan AM; Kalland KH; Krakstad C; Trovik J; Widschwendter M; Salvesen HB Oncotarget; 2014 Feb; 5(4):1052-61. PubMed ID: 24658009 [TBL] [Abstract][Full Text] [Related]
2. The evolution of epigenetic regulators CTCF and BORIS/CTCFL in amniotes. Hore TA; Deakin JE; Marshall Graves JA PLoS Genet; 2008 Aug; 4(8):e1000169. PubMed ID: 18769711 [TBL] [Abstract][Full Text] [Related]
3. The Diverging Routes of BORIS and CTCF: An Interactomic and Phylogenomic Analysis. Jabbari K; Heger P; Sharma R; Wiehe T Life (Basel); 2018 Jan; 8(1):. PubMed ID: 29385718 [TBL] [Abstract][Full Text] [Related]
4. CTCFL (BORIS) mRNA Expression in a Peripheral Giant Cell Granuloma of the Oral Cavity. Zambrano-Galván G; Reyes-Romero M; Bologna-Molina R; Almeda-Ojeda OE; Lemus-Rojero O Case Rep Dent; 2014; 2014():792615. PubMed ID: 25114808 [TBL] [Abstract][Full Text] [Related]
5. The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells. Tiffen JC; Bailey CG; Marshall AD; Metierre C; Feng Y; Wang Q; Watson SL; Holst J; Rasko JE Int J Cancer; 2013 Oct; 133(7):1603-13. PubMed ID: 23553099 [TBL] [Abstract][Full Text] [Related]
6. BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer. Link PA; Zhang W; Odunsi K; Karpf AR Cancer Immun; 2013; 13():6. PubMed ID: 23390377 [TBL] [Abstract][Full Text] [Related]
8. Expression of the epigenetic factor BORIS (CTCFL) in the human genome. de Necochea-Campion R; Ghochikyan A; Josephs SF; Zacharias S; Woods E; Karimi-Busheri F; Alexandrescu DT; Chen CS; Agadjanyan MG; Carrier E J Transl Med; 2011 Dec; 9():213. PubMed ID: 22168535 [TBL] [Abstract][Full Text] [Related]
9. BORIS in human cancers -- a review. Martin-Kleiner I Eur J Cancer; 2012 Apr; 48(6):929-35. PubMed ID: 22019212 [TBL] [Abstract][Full Text] [Related]
10. Peripheral giant cell granuloma. Adlakha VK; Chandna P; Rehani U; Rana V; Malik P J Indian Soc Pedod Prev Dent; 2010; 28(4):293-6. PubMed ID: 21273719 [TBL] [Abstract][Full Text] [Related]
12. Peripheral giant cell granuloma. A report of five cases and review of the literature. Chaparro-Avendaño AV; Berini-Aytés L; Gay-Escoda C Med Oral Patol Oral Cir Bucal; 2005; 10(1):53-7; 48-52. PubMed ID: 15627908 [TBL] [Abstract][Full Text] [Related]
13. The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Klenova EM; Morse HC; Ohlsson R; Lobanenkov VV Semin Cancer Biol; 2002 Oct; 12(5):399-414. PubMed ID: 12191639 [TBL] [Abstract][Full Text] [Related]
14. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Loukinov DI; Pugacheva E; Vatolin S; Pack SD; Moon H; Chernukhin I; Mannan P; Larsson E; Kanduri C; Vostrov AA; Cui H; Niemitz EL; Rasko JE; Docquier FM; Kistler M; Breen JJ; Zhuang Z; Quitschke WW; Renkawitz R; Klenova EM; Feinberg AP; Ohlsson R; Morse HC; Lobanenkov VV Proc Natl Acad Sci U S A; 2002 May; 99(10):6806-11. PubMed ID: 12011441 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and ultrastructural evidence of a modified microvasculature in the giant cell granuloma of the jaws. Lim L; Gibbins JR Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Feb; 79(2):190-8. PubMed ID: 7614183 [TBL] [Abstract][Full Text] [Related]